Fundraising FoxMetagenomi
Berkeley, US · Founded 2018 · 20 known investors
Find your way into Metagenomi
Sign up to see every warm intro you have to Metagenomi
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Metagenomi team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Metagenomi is a genetic medicines company developing therapies based on gene editing technologies to treat patients with serious diseases. It operates in the biotech sector, working on translational and clinical development of genetic medicine programs.
Founders & leadership
Metagenomi was founded in 2018 by Brian Thomas.
Board
Investors · 20
How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us
How we know: RA Capital's portfolio page · funding news · pharmaceutical-technology.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Sozo Ventures's portfolio page · funding news · Not right? Tell us
How we know: funding news · the VCSheet dataset · Not right? Tell us
How we know: pharmaceutical-technology.com · Not right? Tell us
How we know: board seat on SEC Form D · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · pharmaceutical-technology.com · Not right? Tell us
How we know: pharmaceutical-technology.com · Not right? Tell us
How we know: pharmaceutical-technology.com · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
Also in the syndicate · 8
Reported raises · per SEC filings
Form D private placements$345.1M disclosed across 5 rounds · 2019–2022
▶$95.8MraisedJan 2023 · 25 investors · BiotechnologyRule 506(b)
- Willard DereDirector
- Brian C. ThomasExecutive Officer, Director
- Santhosh PalaniDirector
- Risa StackDirector
- Juergen EckhardtDirector
- Sebastian BernalesDirector
- Offering amount
- $100M
- Amount sold
- $95.8M
- Minimum investment
- $100K
- First sale
- Dec 2022
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
▶$175.4MraisedFeb 2022 · 29 investors · BiotechnologyRule 506(b)
- Risa StackDirector
- Brian ThomasExecutive Officer, Director
- Willard DereDirector
- Juergen EckhardtDirector
- Sebastian BernalesDirector
- Santosh PalaniDirector
- Offering amount
- $175.4M
- Amount sold
- $175.4M
- Minimum investment
- $1M
- First sale
- Jan 2022
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
▶$10MraisedMar 2021 · 2 investors · BiotechnologyRule 506(b)
- Andrew LevinDirector
- Sebastian BernalesDirector
- Andrew FarquharsonDirector
- Brian ThomasExecutive Officer, Director, Promoter
- Juergen EckhardtDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Mar 2021
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
▶$37.5MraisedNov 2020 · 11 investors · Other TechnologyRule 506(b)
- Brian ThomasExecutive Officer, Director, Promoter
- Sebastian BernalesDirector
- Andrew FarquharsonDirector
- Juergen EckhardtDirector
- Offering amount
- $40.2M
- Amount sold
- $37.5M
- First sale
- Nov 2020
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
▶$26.4MraisedAug 2019 · 16 investors · Other TechnologyRule 506(b)
- Brian ThomasExecutive Officer, Director, Promoter
- Andrew FarquharsonDirector
- Jak KnowlesDirector
- Offering amount
- $27.3M
- Amount sold
- $26.4M
- First sale
- Aug 2019
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Metagenomi went on to found or lead other companies.
In the news
Frequently asked questions
- What does Metagenomi do?
- Metagenomi is a genetic medicines company developing therapies based on gene editing technologies to treat patients with serious diseases. It operates in the biotech sector, working on translational and clinical development of genetic medicine programs.
- Who founded Metagenomi?
- Metagenomi was founded by Brian Thomas in 2018.
- Who are Metagenomi's investors?
- Metagenomi's investors include Catalio Capital Management, LP, RA Capital, Sozo Ventures, Agent Capital, Frazier Life Sciences, Humboldt, InCube Ventures, Irving Investors and 4 more.
- How much funding has Metagenomi raised?
- Metagenomi has disclosed $345.1M raised across 5 rounds.
- Where is Metagenomi headquartered?
- Metagenomi is headquartered in Berkeley, US.